Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.280
-0.010 (-0.78%)
At close: Nov 14, 2025, 4:00 PM EST
1.260
-0.020 (-1.56%)
After-hours: Nov 14, 2025, 7:36 PM EST
Biomea Fusion Employees
Biomea Fusion had 106 employees as of December 31, 2024. The number of employees increased by 3 or 2.91% compared to the previous year.
Employees
106
Change (1Y)
3
Growth (1Y)
2.91%
Revenue / Employee
n/a
Profits / Employee
-$902,934
Market Cap
90.50M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 106 | 3 | 2.91% |
| Dec 31, 2023 | 103 | 20 | 24.10% |
| Dec 31, 2022 | 83 | 32 | 62.75% |
| Dec 31, 2021 | 51 | 39 | 325.00% |
| Dec 31, 2020 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BMEA News
- 5 days ago - Biomea Fusion to Participate at Jefferies London Healthcare Conference - GlobeNewsWire
- 10 days ago - Biomea Fusion Showcases Preclinical Advances for BMF-650 and Icovamenib with Low Dose Semaglutide at ObesityWeek® 2025 - GlobeNewsWire
- 11 days ago - Biomea Fusion Reports Third Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 16 days ago - Biomea Fusion to Present Poster Presentations at ObesityWeek®2025 - GlobeNewsWire
- 19 days ago - Biomea Fusion Announces First Patient Dosed in Phase I Study of BMF-650 a Next-Generation Oral GLP-1 Receptor Agonist - GlobeNewsWire
- 23 days ago - Biomea Fusion, Inc. (BMEA) Presents at Citi's 2025 SMID Cap Biopharma Call Series Transcript - Seeking Alpha
- 25 days ago - Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series - GlobeNewsWire
- 5 weeks ago - Biomea Fusion, Inc. - Special Call - Seeking Alpha